Aslan Pharmaceuticals: Case Study of a Start-up in Singapore
Most big pharma are now setting up operations in Asia, with China predicted to be the biggest market in pharmaceuticals by 2025. Mark McHale, Chief Scientific Officer at Aslan Pharmaceuticals discusses the set up of the pharma organisation in Singapore over two years ago, looking at the advantages and indeed challenges of operating in the East and the opportunities that lie ahead certainly from 2020 on.
Have Your Say
Rate this feature and giv...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.